MCTA — Charming Medical Limited Class A Ordinary Shares Stock Price, Chart & AI Report

Negative Feb 17, 2026 • 03:55 UTC Benzinga • Prnewswire

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 after its shares spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors are encouraged to contact the firm before February 17, 2026.

MCTA securities fraud class action lawsuit SEC trading suspension promotion scheme shareholder rights false statements

Sentiment note

The company is the subject of a securities fraud class action lawsuit, faced an SEC trading suspension in November 2025, and is accused of making false and misleading statements to the market. The suspension was based on allegations of a promotion scheme involving social media manipulation, resulting in investor losses.

Negative Feb 16, 2026 • 14:51 UTC GlobeNewswire Inc. • The Schall Law Firm

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21-November 12, 2025, for a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 following allegations of a promotion scheme involving social media advisors touting the stock without legitimate news justification. Investors are encouraged to join the case to recover losses.

MCTA securities fraud class action lawsuit SEC trading suspension promotion scheme shareholder rights false statements

Sentiment note

The company is the subject of a securities fraud lawsuit alleging false and misleading statements to the market. An SEC trading suspension was issued based on allegations of a promotion scheme involving social media manipulation, resulting in investor losses.

Negative Feb 15, 2026 • 22:11 UTC GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before the February 17th Class Action Lead Plaintiff Deadline

A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) for allegedly failing to disclose a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. The stock surged from $4.00 to $29.36 between October 10 and November 12, 2025, before the SEC halted trading. Investors who purchased shares during this period have until February 17, 2026, to apply as lead plaintiffs.

MCTA class action lawsuit securities fraud stock manipulation social media promotion scheme SEC trading halt insider trading retail investors

Sentiment note

The company is accused of failing to disclose a fraudulent stock promotion scheme, insider share dumping, and artificial price inflation. The SEC halted trading of the stock, and the company has not provided required information to lift the suspension, indicating serious regulatory and legal violations.

Negative Feb 13, 2026 • 06:03 UTC Benzinga • Prnewswire

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 following a dramatic stock price spike attributed to a promotion scheme involving social media advisors, with no legitimate company news justifying the increase.

MCTA securities fraud class action lawsuit SEC trading suspension promotion scheme shareholder rights false statements

Sentiment note

The company is the subject of a securities fraud class action lawsuit, faced an SEC trading suspension, and is accused of making false and misleading statements to the market. The stock price spike was allegedly driven by a promotion scheme rather than legitimate business developments, resulting in investor losses.

Negative Feb 13, 2026 • 04:12 UTC Benzinga • Prnewswire

Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA

The DJS Law Group has filed a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for securities law violations. The SEC suspended trading of the company's shares following an investigation into an alleged scheme where financial advisors touted shares on social media to artificially boost the stock price. The lawsuit covers the period from October 21, 2025 to November 12, 2025, with a deadline of February 17, 2026 for shareholders to join.

MCTA securities fraud class action lawsuit SEC investigation stock manipulation social media promotion trading suspension

Sentiment note

The company faces serious securities law violations including alleged stock price manipulation through coordinated social media promotion by financial advisors. The SEC has suspended trading of its shares, and shareholders are being encouraged to join a class action lawsuit to recover losses, indicating significant legal and reputational damage.

Negative Feb 12, 2026 • 20:24 UTC Benzinga • Business Wire

Deadline Approaching: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

The Law Offices of Howard G. Smith reminds investors of the February 17, 2026 deadline to file a lead plaintiff motion in a securities fraud class action lawsuit against Charming Medical Limited (NASDAQ: MCTA). The SEC halted trading of MCTA on November 11, 2025 due to potential market manipulation involving social media-based fraudulent stock promotion schemes. The complaint alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity that inflated the stock price.

MCTA securities fraud class action lawsuit market manipulation social media promotion trading halt lead plaintiff stock price inflation

Sentiment note

The company is the subject of an SEC trading halt, a securities fraud class action lawsuit, and allegations of involvement in a fraudulent stock promotion scheme involving market manipulation, false statements, and insider share dumping. These serious regulatory and legal actions indicate significant corporate misconduct and investor losses.

Negative Feb 12, 2026 • 19:49 UTC Benzinga • Business Wire

Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the February 17, 2026 deadline to participate as lead plaintiff in a securities fraud class action lawsuit against Charming Medical Limited (NASDAQ: MCTA). The SEC halted trading of MCTA on November 11, 2025, citing potential market manipulation through social media-based stock promotion schemes. The lawsuit alleges that company defendants made materially false statements and failed to disclose fraudulent stock promotion activities, insider share dumping, and artificial trading activity that inflated the stock price.

MCTA securities fraud class action lawsuit market manipulation SEC trading halt social media promotion stock price inflation insider trading

Sentiment note

The company is the subject of an SEC trading halt, a securities fraud class action lawsuit, and allegations of fraudulent stock promotion schemes involving social media manipulation, insider share dumping, and materially false statements to investors. These serious regulatory and legal actions indicate significant misconduct and investor harm.

Negative Feb 12, 2026 • 19:35 UTC Benzinga • Business Wire

Deadline Alert: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP reminds investors of the February 17, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Charming Medical Limited (MCTA). The SEC halted trading of MCTA securities on November 11, 2025, citing potential market manipulation through social media-based stock promotion schemes. The lawsuit alleges that company defendants made materially false statements and failed to disclose the fraudulent promotion scheme, insider share dumping, and artificial trading activity that inflated the stock price.

MCTA securities fraud class action lawsuit market manipulation social media promotion trading halt SEC enforcement insider trading

Sentiment note

The company is the subject of an SEC trading halt, a securities fraud class action lawsuit, and allegations of involvement in a coordinated stock manipulation scheme involving false social media promotions, insider share dumping, and misleading public statements about business operations and prospects.

Negative Feb 9, 2026 • 21:03 UTC Benzinga • Prnewswire

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking investors who purchased Charming Medical Limited (NASDAQ: MCTA) securities between October 21, 2025, and November 12, 2025, to join a class action lawsuit alleging securities fraud. The company faced an SEC trading suspension in November 2025 after its shares spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors are encouraged to contact the firm before February 17, 2026.

MCTA securities fraud class action lawsuit SEC trading suspension promotion scheme shareholder rights false statements

Sentiment note

The company is the subject of a securities fraud class action lawsuit, faced an SEC trading suspension, and allegedly made false and misleading statements to the market. The suspension was based on allegations of a promotion scheme involving social media manipulation, resulting in investor losses.

Negative Feb 9, 2026 • 17:00 UTC GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Charming Medical Ltd. (NASDAQ: MCTA) alleging that company defendants failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and coordinated share dumping by insiders. The lawsuit covers investors who purchased securities between October 10, 2025 and November 12, 2025. Investors have until February 17, 2026 to request lead plaintiff status.

MCTA class action lawsuit securities fraud stock manipulation fraudulent promotion investor harm disclosure violations

Sentiment note

The company is the subject of a class action lawsuit alleging fraudulent stock promotion schemes, insider share dumping, material misstatements, and failure to disclose material risks to investors. These allegations represent serious securities law violations and corporate misconduct.

Negative Feb 6, 2026 • 20:14 UTC GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

CHARMING MEDICAL CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urges Charming Medical (MCTA) Investors With Large Losses to Contact the Firm Before February 17th

A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) for allegedly failing to disclose a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. The stock surged from $4.00 to $29.36 between October and November 2025 before the SEC halted trading. Investors who purchased shares during the Class Period (October 10 - November 12, 2025) have until February 17, 2026, to apply as lead plaintiff.

MCTA class action lawsuit stock fraud social media manipulation SEC trading halt insider trading stock promotion scheme retail investors

Sentiment note

The company is the subject of a class action lawsuit alleging fraudulent stock promotion, undisclosed insider share dumping, and artificial price inflation. Trading has been halted by the SEC, and investors suffered significant losses as the stock price collapsed after the scheme was exposed.

Negative Feb 5, 2026 • 17:00 UTC GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Charming Medical Ltd. (NASDAQ: MCTA) alleging that company defendants failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and coordinated share dumping by insiders. The lawsuit covers investors who purchased securities between October 10, 2025 and November 12, 2025. Investors have until February 17, 2026 to request lead plaintiff status.

MCTA class action lawsuit securities fraud stock manipulation fraudulent promotion investor harm disclosure violations

Sentiment note

Company is subject to class action lawsuit alleging fraudulent stock promotion scheme, insider share dumping, material misstatements, and failure to disclose risks to investors. These allegations indicate serious securities law violations and investor harm.